CCL2-induced chemokine cascade promotes breast cancer metastasis by enhancing retention of metastasis-associated macrophages
暂无分享,去创建一个
J. Pollard | R. Noy | T. Kitamura | Yu Kato | Binzhi Qian | Jiu-feng Li | L. Cassetta | D. Soong | Gaël Sugano | G. Sugano | Luca Cassetta
[1] K. Mertz,et al. Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis , 2014, Nature.
[2] Will Liao,et al. The cellular and molecular origin of tumor-associated macrophages , 2014, Science.
[3] T. Hussell,et al. Alveolar macrophages: plasticity in a tissue-specific context , 2014, Nature Reviews Immunology.
[4] P. Taylor,et al. Tissue-resident macrophages , 2013, Nature Immunology.
[5] A. Kajaste-Rudnitski,et al. M1 polarization of human monocyte-derived macrophages restricts pre and postintegration steps of HIV-1 replication , 2013, AIDS.
[6] Constance Auvynet,et al. Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice. , 2013, Neoplasia.
[7] A. Tolcher,et al. A first-in-human, first-in-class, phase I study of carlumab (CNTO 888), a human monoclonal antibody against CC-chemokine ligand 2 in patients with solid tumors , 2013, Cancer Chemotherapy and Pharmacology.
[8] T. Schall,et al. CCR1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease. , 2012, Blood.
[9] P. Tak,et al. Chemokine receptor CCR1 antagonist CCX354-C treatment for rheumatoid arthritis: CARAT-2, a randomised, placebo controlled clinical trial , 2012, Annals of the rheumatic diseases.
[10] Douglas Hanahan,et al. Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment Prospects and Obstacles for Therapeutic Targeting of Function-enabling Stromal Cell Types , 2022 .
[11] J. Massagué,et al. Macrophage binding to receptor VCAM-1 transmits survival signals in breast cancer cells that invade the lungs. , 2011, Cancer cell.
[12] H. Okada,et al. Systemic delivery of neutralizing antibody targeting CCL2 for glioma therapy , 2011, Journal of Neuro-Oncology.
[13] Jinghang Zhang,et al. CCL2 recruits inflammatory monocytes to facilitate breast tumor metastasis , 2011, Nature.
[14] G. Kelsoe,et al. Inflammation Triggers Emergency Granulopoiesis through a Density-Dependent Feedback Mechanism , 2011, PloS one.
[15] T. Schall,et al. Overcoming hurdles in developing successful drugs targeting chemokine receptors , 2011, Nature Reviews Immunology.
[16] T. Schall,et al. Pharmacokinetic and Pharmacodynamic Evaluation of the Novel CCR1 Antagonist CCX354 in Healthy Human Subjects: Implications for Selection of Clinical Dose , 2011, Clinical pharmacology and therapeutics.
[17] K. Ariyoshi,et al. Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation. , 2010, Biochemical and biophysical research communications.
[18] M. Aoki,et al. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model , 2010, Proceedings of the National Academy of Sciences.
[19] Jeffrey W. Pollard,et al. Macrophage Diversity Enhances Tumor Progression and Metastasis , 2010, Cell.
[20] Matthew J. Craig,et al. CCL2 and Interleukin-6 Promote Survival of Human CD11b+ Peripheral Blood Mononuclear Cells and Induce M2-type Macrophage Polarization* , 2009, The Journal of Biological Chemistry.
[21] K. Matsushima,et al. CCL3-CCR5 axis regulates intratumoral accumulation of leukocytes and fibroblasts and promotes angiogenesis in murine lung metastasis process. , 2009, Journal of immunology.
[22] Xin Lu,et al. Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and Bone* , 2009, The Journal of Biological Chemistry.
[23] Ruth J. Muschel,et al. A Distinct Macrophage Population Mediates Metastatic Breast Cancer Cell Extravasation, Establishment and Growth , 2009, PloS one.
[24] J. Pollard,et al. Microenvironmental regulation of metastasis , 2009, Nature Reviews Cancer.
[25] J. Pollard. Trophic macrophages in development and disease , 2009, Nature Reviews Immunology.
[26] William King,et al. High-density gene expression analysis of tumor-associated macrophages from mouse mammary tumors. , 2009, The American journal of pathology.
[27] K. Matsushima,et al. CCL3-CCR5 Axis Regulates Intratumoral Accumulation of Leukocytes and Fibroblasts and Promotes Angiogenesis in Murine Lung Metastasis Process1 , 2008, The Journal of Immunology.
[28] S. Kaneko,et al. Tumor cell apoptosis induces tumor‐specific immunity in a CC chemokine receptor 1‐ and 5‐dependent manner in mice , 2008, Journal of leukocyte biology.
[29] F. Pépin,et al. Stromal gene expression predicts clinical outcome in breast cancer , 2008, Nature Medicine.
[30] G. Bernardini,et al. CCL3 and CXCL12 regulate trafficking of mouse bone marrow NK cell subsets. , 2008, Blood.
[31] T. Hohl,et al. Monocyte-mediated defense against microbial pathogens. , 2008, Annual review of immunology.
[32] M. Schaller,et al. A key role for CC chemokine receptor 1 in T-cell-mediated respiratory inflammation. , 2008, The American journal of pathology.
[33] Adrian L Harris,et al. Macrophages and the hypoxic tumour microenvironment. , 2007, Frontiers in bioscience : a journal and virtual library.
[34] J. Pollard,et al. Conditional deletion of the colony stimulating factor‐1 receptor (c‐fms proto‐oncogene) in mice , 2006, Genesis.
[35] M. J. Ehrke,et al. Distant metastasis from subcutaneously grown E0771 medullary breast adenocarcinoma. , 2005, Anticancer research.
[36] Andy J. Minn,et al. Genes that mediate breast cancer metastasis to lung , 2005, Nature.
[37] C. Hogaboam,et al. MIP‐1α[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF‐α and LTB4 , 2005 .
[38] VC Jordan. The challenges in translating present knowledge of the molecular biology of breast cancer into clinical use , 2005, Breast Cancer Research.
[39] N. Callander,et al. MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells , 2005 .
[40] C. Alpers,et al. J Am Soc Nephrol 15: 337–347, 2004 Chemokine Receptor CCR1 But Not CCR5 Mediates Leukocyte Recruitment and Subsequent Renal Fibrosis after Unilateral Ureteral , 2022 .
[41] Jeffrey W Pollard,et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. , 2003, The American journal of pathology.
[42] Noam Brown,et al. The role of tumour‐associated macrophages in tumour progression: implications for new anticancer therapies , 2002, The Journal of pathology.
[43] L. Santambrogio,et al. RANTES-Induced Chemokine Cascade in Dendritic Cells1 , 2001, The Journal of Immunology.
[44] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[45] R. Horuk,et al. Specialized roles of the chemokine receptors CCR1 and CCR5 in the recruitment of monocytes and T(H)1-like/CD45RO(+) T cells. , 2001, Blood.
[46] D. Gemsa,et al. Increase of CCR1 and CCR5 expression and enhanced functional response to MIP‐1α during differentiation of human monocytes to macrophages , 2001, Journal of leukocyte biology.
[47] M. Dorf,et al. Macrophage Inflammatory Protein-2 and KC Induce Chemokine Production by Mouse Astrocytes1 , 2000, The Journal of Immunology.
[48] K. Jeng,et al. Differential Expression and Regulation of Macrophage Inflammatory Protein (MIP)-1α and MIP-2 Genes by Alveolar and Peritoneal Macrophages in LPS-Hyporesponsive C3H/HeJ Mice , 2000 .
[49] Yolande Chvatchko,et al. A Key Role for Cc Chemokine Receptor 4 in Lipopolysaccharide-Induced Endotoxic Shock , 2000, The Journal of experimental medicine.
[50] R. Rees,et al. Chemokines induce the cellular migration of MCF-7 human breast carcinoma cells: Subpopulations of tumour cells display positive and negative chemotaxis and differential in vivo growth potentials , 1999, Clinical & Experimental Metastasis.
[51] M. Burdick,et al. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. , 1997, Journal of immunology.
[52] R. Rees,et al. Chemokines induce migrational responses in human breast carcinoma cell lines , 1997, International journal of cancer.
[53] A. Harris,et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. , 1996, Cancer research.
[54] D. Taub,et al. Chemokines regulate T cell adherence to recombinant adhesion molecules and extracellular matrix proteins. , 1996, Journal of immunology.
[55] T. Schall,et al. Molecular cloning, functional expression, and signaling characteristics of a C-C chemokine receptor , 1993, Cell.
[56] K. Matsushima,et al. Brief Definitive Report Purification and Characterization of a Novel Monocyte Chemotactic and Activating Factor Produced by a Human Myelomonocytic Cell Line , 2022 .
[57] P. Tynan,et al. Survival of mononuclear phagocytes depends on a lineage-specific growth factor that the differentiated cells selectively destroy , 1982, Cell.
[58] T. Schall,et al. CCR 1 blockade reduces tumor burden and osteolysis in vivo in a mouse model of myeloma bone disease * , 2012 .
[59] M. Fujimoto,et al. Tumorigenesis and Neoplastic Progression Host-Derived MCP-1 and MIP-1 Regulate Protective Anti-Tumor Immunity to Localized and Metastatic B 16 Melanoma , 2011 .
[60] A. Jemal,et al. Global Cancer Statistics , 2011 .
[61] J. Gregg,et al. Syngeneic mouse mammary carcinoma cell lines: Two closely related cell lines with divergent metastatic behavior , 2005, Clinical & Experimental Metastasis.
[62] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[63] H. Nawata,et al. Macrophage inflammatory protein 1alpha enhances in a different manner adhesion of hematopoietic progenitor cells from bone marrow, cord blood, and mobilized peripheral blood. , 1999, Experimental hematology.